EUVIMEDEUVIMED entdecken
LeitlinieÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance document

Miguel Escobar, Riitta Lassila, Carine Bekdache, Tarek Owaidah, Michelle Sholzberg

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2024.10.033 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Miguel Escobar und 4 weiteren Autor:innen. Beteiligte Einrichtung: The University of Texas Health Science Center, Gulf States Hemophilia Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Hemophilia A, Thrombosis, Fibrinolytic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer, Amgen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here, we summarize the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance document recommendations on antithrombotic therapy for cardiovascular indications among patients with hemophilia. This summary includes a discussion on primary and secondary prevention of venous and arterial thrombosis. The guidance document considers distinct and controversial challenges presented by various clinical scenarios in this aging patient population and provides thoughtful recommendations to assist the hemophilia care provider in clinical decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AThrombosisFibrinolytic AgentsHumansRisk FactorsTreatment OutcomeEuropeHematologySecondary PreventionSocieties, Medical

Stichwörter der Autor:innen

antithrombotic therapycardiovascular diseaseclinical guidelineshemophiliavenous thromboembolism

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • The University of Texas Health Science Center, Gulf States Hemophilia Center, Houston, Texas, USA.
  • Department of Hematology, Coagulation Disorders, Helsinki University Hospital, Helsinki, Finland.
  • Hematology-Oncology Clinical Research Group, St Michael's Hospital, Toronto, Ontario, Canada.
  • King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Departments of Medicine and Laboratory Medicine and Pathobiology, St Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada. Electronic address: Michelle.Sholzberg@unityheal…

Förderung

  • Pfizer
  • Amgen

Zitieren

APA

Escobar, M., Lassila, R., Bekdache, C., Owaidah, T., & Sholzberg, M. (2025). Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance document. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.10.033

Vancouver

Escobar M, Lassila R, Bekdache C, Owaidah T, Sholzberg M. Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance document. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2024.10.033

BibTeX
@article{Escobar2025,
  author = {Escobar, Miguel and Lassila, Riitta and Bekdache, Carine and Owaidah, Tarek and Sholzberg, Michelle},
  title = {Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance document},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2024.10.033}
}
Kostenlos starten →